Company of the week: Excedr
Emerging from UC Berkeley camaraderie, Excedr has evolved into a key player in the biotech sector, offering a tailored leasing program that alleviates the financial burden of acquiring essential lab equipment. In a recent PhunD chat with CEO Jon Chee, I got a closer look at Excedr's trajectory since its inception in 2011, unraveling a dedicated effort to foster a conducive environment for groundbreaking research.
Excedr has fostered meaningful collaborations with a variety of esteemed institutions and companies such as Abbott, Distributed Bio, Stanford University, Clinical Genomics, UC Berkeley, and Centivax among others. These partnerships underscore Excedr's extensive reach and positive impact in the scientific community.
Their website hosts heartfelt testimonials from partners, reflecting the transformative influence Excedr has had on their operations. For instance, Jessica Grossman, CEO at IgGenix, and Jacob Glanville, Founder, CEO, & President at Centivax, both commend Excedr for being a pivotal partner in advancing their respective scientific pursuits.
Beyond leasing, Excedr's CEO Jon Chee hosts "The Biotech Startups Podcast," providing a platform for scientist-entrepreneurs to garner insights from biotech leaders, bridging the academia-industry divide.
Discover more about Excedr's leasing program and delve into the podcast: [Excedr's Website] | The Biotech Startups Podcast
#Excedr #BiotechInnovation #CollaborativeGrowth
